Magdalena Franco

Title: Magdalena Franco: Innovator in Biothreat Detection

Introduction

Magdalena Franco is a prominent inventor based in Livermore, CA (US). She has made significant contributions to the field of immunogenic epitope detection, particularly in relation to biothreat agents and emerging pathogens. Her work is crucial for the development of peptide vaccines and therapeutics.

Latest Patents

Franco holds a patent titled "Methods for rapid detection of immunogenic epitopes in biothreat agents and emerging pathogens for peptide vaccines and therapeutics." This innovative patent describes a newly developed generalizable screening method that enables efficient identification of epitopes within the proteomes of pathogenic agents. The patent also discloses systems that facilitate the method, as well as the epitopes discovered using this approach. She has 1 patent to her name.

Career Highlights

Magdalena Franco is affiliated with Lawrence Livermore National Security, LLC, where she applies her expertise in immunology and biothreat detection. Her work at this institution underscores her commitment to advancing public health and safety through innovative research.

Collaborations

Franco collaborates with notable colleagues, including Nicole Collette and Patrik D'haeseleer. These partnerships enhance her research efforts and contribute to the development of effective solutions in her field.

Conclusion

Magdalena Franco is a dedicated inventor whose work in immunogenic epitope detection is paving the way for advancements in vaccine development and therapeutic strategies. Her contributions are vital in addressing the challenges posed by biothreat agents and emerging pathogens.